Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
1,072
Price
$2.48
Total Value
$2,658.56
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Jul 17, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jul 21, 2026 |
| Shares Purchased | 1,072 |
| Price per Share | $2.48 |
| Total Value | $2,658.56 |
| Shares Owned After | 52,072 |
| Derivative | No |
| Accession Number | 0001882764-26-000006 |
| Document | View SEC Filing |